Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Pharma Marketing Has Never Had Its Defining Infrastructure Moment
Harshit Jain, MD, is Founder & Global CEO of Doceree. There is a meeting that I've seen happen at some point in every major pharma company. The meeting has a room full of smart, experienced marketers, slides loaded with data and dashboards…
Piramal Pharma Limited Announces Results for Q1 FY27
MUMBAI, India, July 29, 2026 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30…
Sun Pharma gets green signal on semaglutide in Brazil, its second export market
Sun Pharmaceutical Industries has received approval from the Brazilian Health Regulatory Agency – ANVISA, to manufacture and market semaglutide injection in Brazil for the treatment of adults with inadequately controlled type 2 diabetes…
Ajanta Pharma Q1 results: PAT rises 31% to ₹334 cr
Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to ₹334 crore for the first quarter ended June 30. The company had posted a profit after tax (PAT) of ₹255 crore in the corresponding period of the last…
Q1 Results 30th July Live: Bajaj Finance, M&M, Tata Steel, Gillette, Vedanta, Torrent Pharma, Hyundai Motor, IRFC, Swiggy, NSDL, Niva Bupa, Mankind Pharma, Mazagon Dock, Thermax, Ajanta Pharma, Nuvama Wealth to announce Q1 results, Adani Ports, Asian Paints, Colgate, Waaree, Dabur shares down; Eiche
Q1 Results Today, 30th July 2026 Live Updates: Get real-time Q1 FY27 earnings updates, profit growth, revenue numbers and management outlook from Saven Technologies, Aarcon Facilities, Aarti Industries, Archean Chemical Industries, Anlon…
Urogen Pharma (URGN) to Announce Quarterly Earnings on Thursday
Urogen Pharma (NASDAQ:URGN - Get Free Report) is expected to be releasing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.2650) per share and revenue of $63.5460 million…
Athira Pharma (NASDAQ:LONA) Stock Rating Upgraded by Citizens Jmp
Athira Pharma (NASDAQ:LONA - Get Free Report) was upgraded by Citizens Jmp from a 'market perform' rating to an 'outperform' rating in a research note issued on Thursday, Marketbeat Ratings reports. The firm presently has a $18.00 price target on…
Torrent Pharma FYQ1 PAT rises 3.3% as JB integration costs & higher finance charges weigh on earnings
Torrent Pharmaceuticals, the flagship company of Gujarat-based Torrent Group, reported a modest 3.3 per cent year-on-year increase in consolidated net profit for the first quarter of FY27 as higher finance costs, depreciation and one-time…
Ascendis Pharma A/S $ASND Stock Holdings Reduced by Tri Locum Partners LP
Tri Locum Partners LP reduced its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 3.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 255,332…
Ascendis Pharma A/S (ASND) Expected to Release Quarterly Earnings on Thursday
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) is anticipated to announce its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Ascendis Pharma A/S to post earnings of $1.29 per share and revenue of $430.2140…
Sei Investments Co. Sells 99,990 Shares of Royalty Pharma PLC $RPRX
Sei Investments Co. decreased its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 379,726…
Empowered Funds LLC Acquires 14,438 Shares of Ascendis Pharma A/S $ASND
Empowered Funds LLC raised its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 39.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor…
Renaissance Technologies LLC Purchases Shares of 117,332 Ascendis Pharma A/S $ASND
Renaissance Technologies LLC purchased a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor…
NewAmsterdam Pharma Company N.V. $NAMS Stake Boosted by Stempoint Capital LP
Stempoint Capital LP lifted its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 147.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned…
Janus Henderson Group PLC Has $978.61 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIO
Janus Henderson Group PLC grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 19.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund…
Receive a Daily briefing on Pharma Industry News
Get Started